Last $2.63 USD
Change Today +0.03 / 1.15%
Volume 619.1K
OGXI On Other Exchanges
Symbol
Exchange
Munich
NASDAQ CM
As of 3:10 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for oncogenex pharmaceutical inc (OGXI)

Year over year, OncoGenex Pharmaceuticals, Inc. has seen their bottom line shrink from a loss of $21.1M USD to an even larger loss of $31.8M USD despite an increase in revenues from $20.1M USD to $29.9M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues13.65.520.129.9
TOTAL REVENUES13.65.520.129.9
Cost of Goods Sold18.521.639.955.3
GROSS PROFIT-4.9-16.1-19.9-25.4
Selling General & Admin Expenses, Total5.86.27.89.9
OTHER OPERATING EXPENSES, TOTAL5.86.27.89.9
OPERATING INCOME-10.7-22.3-27.6-35.3
Interest and Investment Income0.10.20.30.2
NET INTEREST EXPENSE0.10.20.30.2
Currency Exchange Gains (Loss)0.0------
Other Non-Operating Income (Expenses)-0.97.44.43.3
EBT, EXCLUDING UNUSUAL ITEMS-11.5-14.7-23.0-31.8
Merger & Restructuring Charges-4.0--1.7--
Gain (Loss) on Sale of Assets----0.2--
EBT, INCLUDING UNUSUAL ITEMS-15.6-14.7-21.1-31.8
Income Tax Expense-3.0------
Earnings from Continuing Operations-12.6-14.7-21.1-31.8
NET INCOME-12.6-14.7-21.1-31.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-12.6-14.7-21.1-31.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-12.6-14.7-21.1-31.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $2.63 USD +0.03

OGXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OGXI.
View Industry Companies
 

Industry Analysis

OGXI

Industry Average

Valuation OGXI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.